

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adult feeding behavior (GO:0008343) | 6.30478812 |
| 2 | regulation of response to food (GO:0032095) | 5.40842659 |
| 3 | regulation of appetite (GO:0032098) | 4.95712582 |
| 4 | protein complex biogenesis (GO:0070271) | 4.16598121 |
| 5 | rRNA methylation (GO:0031167) | 4.07104807 |
| 6 | rRNA modification (GO:0000154) | 4.06241599 |
| 7 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.00136330 |
| 8 | histamine transport (GO:0051608) | 3.99544222 |
| 9 | response to pheromone (GO:0019236) | 3.88675904 |
| 10 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.72166097 |
| 11 | NADH dehydrogenase complex assembly (GO:0010257) | 3.72166097 |
| 12 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.72166097 |
| 13 | histamine secretion (GO:0001821) | 3.71697384 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.66457888 |
| 15 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.64381777 |
| 16 | GTP biosynthetic process (GO:0006183) | 3.63064573 |
| 17 | protein deneddylation (GO:0000338) | 3.61928462 |
| 18 | cellular ketone body metabolic process (GO:0046950) | 3.61433714 |
| 19 | exocrine pancreas development (GO:0031017) | 3.48882574 |
| 20 | chaperone-mediated protein transport (GO:0072321) | 3.45690391 |
| 21 | protein K11-linked deubiquitination (GO:0035871) | 3.42180633 |
| 22 | cullin deneddylation (GO:0010388) | 3.36522982 |
| 23 | aggressive behavior (GO:0002118) | 3.34589917 |
| 24 | negative regulation of response to food (GO:0032096) | 3.31783880 |
| 25 | negative regulation of appetite (GO:0032099) | 3.31783880 |
| 26 | gamma-aminobutyric acid transport (GO:0015812) | 3.31716019 |
| 27 | negative regulation of dendrite development (GO:2000171) | 3.29814302 |
| 28 | regulation of neurotransmitter uptake (GO:0051580) | 3.27189157 |
| 29 | protein polyglutamylation (GO:0018095) | 3.25985333 |
| 30 | ketone body metabolic process (GO:1902224) | 3.25625042 |
| 31 | estrogen biosynthetic process (GO:0006703) | 3.17856557 |
| 32 | nonmotile primary cilium assembly (GO:0035058) | 3.17761100 |
| 33 | glycosphingolipid biosynthetic process (GO:0006688) | 3.17738750 |
| 34 | inositol phosphate catabolic process (GO:0071545) | 3.15525254 |
| 35 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.14321424 |
| 36 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.10882287 |
| 37 | UTP biosynthetic process (GO:0006228) | 3.09628956 |
| 38 | cornea development in camera-type eye (GO:0061303) | 3.08850394 |
| 39 | epithelial cilium movement (GO:0003351) | 3.03179895 |
| 40 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.00922551 |
| 41 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.99526671 |
| 42 | negative regulation of heart rate (GO:0010459) | 2.98193837 |
| 43 | rhodopsin mediated signaling pathway (GO:0016056) | 2.96501703 |
| 44 | somite development (GO:0061053) | 2.91723334 |
| 45 | azole transport (GO:0045117) | 2.90067011 |
| 46 | regulation of protein kinase A signaling (GO:0010738) | 2.87039393 |
| 47 | regulation of telomere maintenance (GO:0032204) | 2.86842884 |
| 48 | UTP metabolic process (GO:0046051) | 2.86175300 |
| 49 | arginine catabolic process (GO:0006527) | 2.85897961 |
| 50 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.83685017 |
| 51 | positive regulation of response to nutrient levels (GO:0032109) | 2.83685017 |
| 52 | negative regulation of telomere maintenance (GO:0032205) | 2.82441583 |
| 53 | response to dietary excess (GO:0002021) | 2.81671288 |
| 54 | eye photoreceptor cell differentiation (GO:0001754) | 2.80645275 |
| 55 | photoreceptor cell differentiation (GO:0046530) | 2.80645275 |
| 56 | positive regulation of meiosis (GO:0045836) | 2.79237690 |
| 57 | positive regulation of mitochondrial fission (GO:0090141) | 2.78487304 |
| 58 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.78309189 |
| 59 | regulation of chemokine biosynthetic process (GO:0045073) | 2.77974832 |
| 60 | retinal cone cell development (GO:0046549) | 2.75043677 |
| 61 | polyol catabolic process (GO:0046174) | 2.74519412 |
| 62 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.74134373 |
| 63 | inositol phosphate dephosphorylation (GO:0046855) | 2.74134373 |
| 64 | positive regulation of action potential (GO:0045760) | 2.73037399 |
| 65 | startle response (GO:0001964) | 2.72417376 |
| 66 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.71986205 |
| 67 | regulation of action potential (GO:0098900) | 2.69636985 |
| 68 | respiratory chain complex IV assembly (GO:0008535) | 2.69472361 |
| 69 | kidney morphogenesis (GO:0060993) | 2.69361912 |
| 70 | C4-dicarboxylate transport (GO:0015740) | 2.68034082 |
| 71 | piRNA metabolic process (GO:0034587) | 2.67745336 |
| 72 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.66497093 |
| 73 | cytochrome complex assembly (GO:0017004) | 2.64995648 |
| 74 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.64593889 |
| 75 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.63595372 |
| 76 | axoneme assembly (GO:0035082) | 2.63427835 |
| 77 | neuronal action potential propagation (GO:0019227) | 2.63362388 |
| 78 | electron transport chain (GO:0022900) | 2.60835613 |
| 79 | positive regulation of meiotic cell cycle (GO:0051446) | 2.60186978 |
| 80 | respiratory electron transport chain (GO:0022904) | 2.59705775 |
| 81 | neuropeptide signaling pathway (GO:0007218) | 2.59501056 |
| 82 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.59076191 |
| 83 | centriole replication (GO:0007099) | 2.58207771 |
| 84 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.54099694 |
| 85 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.54099694 |
| 86 | pseudouridine synthesis (GO:0001522) | 2.53820579 |
| 87 | ATP synthesis coupled proton transport (GO:0015986) | 2.50315975 |
| 88 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.50315975 |
| 89 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.48886113 |
| 90 | nitric oxide mediated signal transduction (GO:0007263) | 2.48403350 |
| 91 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.48279568 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.47748309 |
| 93 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.46450273 |
| 94 | fatty acid transmembrane transport (GO:1902001) | 2.45447175 |
| 95 | positive regulation of growth hormone secretion (GO:0060124) | 2.44433622 |
| 96 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.44260556 |
| 97 | neuronal ion channel clustering (GO:0045161) | 2.44226444 |
| 98 | behavioral defense response (GO:0002209) | 2.43301769 |
| 99 | behavioral fear response (GO:0001662) | 2.43301769 |
| 100 | DNA double-strand break processing (GO:0000729) | 2.42968216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.44682559 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.15594942 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.96923289 |
| 4 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.92802195 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.87643442 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.86147459 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.43444800 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.40237115 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.37925948 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.23394009 |
| 11 | EWS_26573619_Chip-Seq_HEK293_Human | 2.22486439 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.22127325 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.20008338 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.18389474 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 2.15653344 |
| 16 | FUS_26573619_Chip-Seq_HEK293_Human | 2.10406669 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.06092469 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.99990406 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95667390 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.87233530 |
| 21 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.82397886 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.78991643 |
| 23 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76223403 |
| 24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.75643443 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72414083 |
| 26 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.72350481 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64633650 |
| 28 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.55504079 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53533373 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53173268 |
| 31 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.51678211 |
| 32 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50026755 |
| 33 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47127313 |
| 34 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.46188004 |
| 35 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44598290 |
| 36 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.41239670 |
| 37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.39580838 |
| 38 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39457932 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.39347226 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39220769 |
| 41 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.39189741 |
| 42 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39133998 |
| 43 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.38640661 |
| 44 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.38621253 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37744480 |
| 46 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.36741680 |
| 47 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36711753 |
| 48 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.36310159 |
| 49 | TCF4_23295773_ChIP-Seq_U87_Human | 1.34685749 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34536376 |
| 51 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.33877888 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32464986 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31718199 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30511505 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30139937 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30107505 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.29404365 |
| 58 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29069203 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28417754 |
| 60 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.27360210 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25755226 |
| 62 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.25698884 |
| 63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.25565038 |
| 64 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.25345212 |
| 65 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23811904 |
| 66 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23234567 |
| 67 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23018090 |
| 68 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.22946795 |
| 69 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22557023 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21870414 |
| 71 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21442894 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21442894 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18728314 |
| 74 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16810839 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16225933 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15988448 |
| 77 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.15649261 |
| 78 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14278216 |
| 79 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.13043134 |
| 80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12571588 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12571588 |
| 82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10397087 |
| 83 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09225749 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08832486 |
| 85 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08646748 |
| 86 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08643506 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08197004 |
| 88 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08191435 |
| 89 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.06857464 |
| 90 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05519507 |
| 91 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04644985 |
| 92 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04483204 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03635849 |
| 94 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03093207 |
| 95 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02772483 |
| 96 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01241994 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.01078796 |
| 98 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.01078796 |
| 99 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00923982 |
| 100 | JUN_21703547_ChIP-Seq_K562_Human | 0.99753018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.62642972 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.70432082 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 2.63181576 |
| 4 | MP0001529_abnormal_vocalization | 2.62824187 |
| 5 | MP0005423_abnormal_somatic_nervous | 2.51118726 |
| 6 | MP0001501_abnormal_sleep_pattern | 2.30568202 |
| 7 | MP0006072_abnormal_retinal_apoptosis | 2.18138240 |
| 8 | MP0005174_abnormal_tail_pigmentation | 2.17396533 |
| 9 | MP0004270_analgesia | 2.07582491 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.03683171 |
| 11 | MP0003186_abnormal_redox_activity | 1.96683562 |
| 12 | MP0005551_abnormal_eye_electrophysiolog | 1.96672100 |
| 13 | MP0004147_increased_porphyrin_level | 1.90706192 |
| 14 | MP0001986_abnormal_taste_sensitivity | 1.84358266 |
| 15 | MP0002938_white_spotting | 1.82159305 |
| 16 | MP0002736_abnormal_nociception_after | 1.81197783 |
| 17 | MP0003787_abnormal_imprinting | 1.76967356 |
| 18 | MP0005379_endocrine/exocrine_gland_phen | 1.76780001 |
| 19 | MP0003172_abnormal_lysosome_physiology | 1.74446606 |
| 20 | MP0008995_early_reproductive_senescence | 1.73525925 |
| 21 | MP0008877_abnormal_DNA_methylation | 1.70219616 |
| 22 | MP0002909_abnormal_adrenal_gland | 1.68381392 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.67580658 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.64185374 |
| 25 | MP0002272_abnormal_nervous_system | 1.61352731 |
| 26 | MP0003718_maternal_effect | 1.61235114 |
| 27 | MP0004885_abnormal_endolymph | 1.56009965 |
| 28 | MP0008775_abnormal_heart_ventricle | 1.55242957 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 1.54212997 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.53606635 |
| 31 | MP0008789_abnormal_olfactory_epithelium | 1.52162964 |
| 32 | MP0003786_premature_aging | 1.48982224 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.47413259 |
| 34 | MP0009745_abnormal_behavioral_response | 1.47369512 |
| 35 | MP0008058_abnormal_DNA_repair | 1.47261944 |
| 36 | MP0004924_abnormal_behavior | 1.41565946 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.41565946 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.40408465 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.40022762 |
| 40 | MP0005360_urolithiasis | 1.37790242 |
| 41 | MP0005253_abnormal_eye_physiology | 1.35788922 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.35177551 |
| 43 | MP0001486_abnormal_startle_reflex | 1.32921446 |
| 44 | MP0002163_abnormal_gland_morphology | 1.30754781 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.27556443 |
| 46 | MP0001970_abnormal_pain_threshold | 1.24434798 |
| 47 | MP0008872_abnormal_physiological_respon | 1.23935639 |
| 48 | MP0004133_heterotaxia | 1.23714330 |
| 49 | MP0005365_abnormal_bile_salt | 1.23098091 |
| 50 | MP0009046_muscle_twitch | 1.21986915 |
| 51 | MP0002064_seizures | 1.20002671 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.19101332 |
| 53 | MP0003635_abnormal_synaptic_transmissio | 1.16732428 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 1.13869188 |
| 55 | MP0000427_abnormal_hair_cycle | 1.12130760 |
| 56 | MP0004484_altered_response_of | 1.11682959 |
| 57 | MP0001873_stomach_inflammation | 1.11590191 |
| 58 | MP0003646_muscle_fatigue | 1.10230964 |
| 59 | MP0005332_abnormal_amino_acid | 1.08397765 |
| 60 | MP0004043_abnormal_pH_regulation | 1.05436130 |
| 61 | MP0002234_abnormal_pharynx_morphology | 1.05382116 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.04822912 |
| 63 | MP0000631_abnormal_neuroendocrine_gland | 1.00419019 |
| 64 | MP0010094_abnormal_chromosome_stability | 1.00395027 |
| 65 | MP0002229_neurodegeneration | 0.99784558 |
| 66 | MP0004215_abnormal_myocardial_fiber | 0.97868300 |
| 67 | MP0006292_abnormal_olfactory_placode | 0.96806200 |
| 68 | MP0002557_abnormal_social/conspecific_i | 0.95789266 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 0.95677599 |
| 70 | MP0002063_abnormal_learning/memory/cond | 0.95383031 |
| 71 | MP0002735_abnormal_chemical_nociception | 0.94957994 |
| 72 | MP0001764_abnormal_homeostasis | 0.93117541 |
| 73 | MP0002160_abnormal_reproductive_system | 0.91959620 |
| 74 | MP0002693_abnormal_pancreas_physiology | 0.90458938 |
| 75 | MP0003122_maternal_imprinting | 0.89471659 |
| 76 | MP0000015_abnormal_ear_pigmentation | 0.87569763 |
| 77 | MP0005535_abnormal_body_temperature | 0.86558942 |
| 78 | MP0003950_abnormal_plasma_membrane | 0.86429543 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.86232698 |
| 80 | MP0004742_abnormal_vestibular_system | 0.86170293 |
| 81 | MP0001984_abnormal_olfaction | 0.85596542 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85291291 |
| 83 | MP0003011_delayed_dark_adaptation | 0.84535401 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.84433808 |
| 85 | MP0005408_hypopigmentation | 0.83545571 |
| 86 | MP0002095_abnormal_skin_pigmentation | 0.83218090 |
| 87 | MP0005499_abnormal_olfactory_system | 0.82468596 |
| 88 | MP0005394_taste/olfaction_phenotype | 0.82468596 |
| 89 | MP0005220_abnormal_exocrine_pancreas | 0.82414994 |
| 90 | MP0002067_abnormal_sensory_capabilities | 0.80921253 |
| 91 | MP0003633_abnormal_nervous_system | 0.80818659 |
| 92 | MP0004142_abnormal_muscle_tone | 0.79724773 |
| 93 | MP0001188_hyperpigmentation | 0.79313980 |
| 94 | MP0000358_abnormal_cell_content/ | 0.79147758 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.78294290 |
| 96 | MP0001293_anophthalmia | 0.78152869 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.77258236 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.77191227 |
| 99 | MP0006276_abnormal_autonomic_nervous | 0.76376879 |
| 100 | MP0005389_reproductive_system_phenotype | 0.76252534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.86544361 |
| 2 | Absent/shortened dynein arms (HP:0200106) | 3.86544361 |
| 3 | Medial flaring of the eyebrow (HP:0010747) | 3.64170245 |
| 4 | Hemiparesis (HP:0001269) | 3.60938914 |
| 5 | Renal Fanconi syndrome (HP:0001994) | 3.27392769 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.25739619 |
| 7 | Nephronophthisis (HP:0000090) | 3.24366201 |
| 8 | Febrile seizures (HP:0002373) | 3.17803219 |
| 9 | Acute necrotizing encephalopathy (HP:0006965) | 3.16642175 |
| 10 | Lipid accumulation in hepatocytes (HP:0006561) | 3.10194774 |
| 11 | Pancreatic fibrosis (HP:0100732) | 3.07130086 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.01685465 |
| 13 | Tubular atrophy (HP:0000092) | 3.01391973 |
| 14 | Mitochondrial inheritance (HP:0001427) | 2.96567239 |
| 15 | Hyperventilation (HP:0002883) | 2.94285590 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 2.89689627 |
| 17 | Type II lissencephaly (HP:0007260) | 2.89608413 |
| 18 | Progressive macrocephaly (HP:0004481) | 2.85215170 |
| 19 | Acute encephalopathy (HP:0006846) | 2.81024787 |
| 20 | Increased CSF lactate (HP:0002490) | 2.77718336 |
| 21 | Abnormality of the renal medulla (HP:0100957) | 2.73852657 |
| 22 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.69927897 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 2.69813837 |
| 24 | Abnormality of the renal cortex (HP:0011035) | 2.63325909 |
| 25 | Gait imbalance (HP:0002141) | 2.57429306 |
| 26 | Hepatocellular necrosis (HP:0001404) | 2.57340343 |
| 27 | Exertional dyspnea (HP:0002875) | 2.56501752 |
| 28 | Increased muscle lipid content (HP:0009058) | 2.55503553 |
| 29 | Congenital primary aphakia (HP:0007707) | 2.55278644 |
| 30 | Abnormality of renal resorption (HP:0011038) | 2.37452558 |
| 31 | Focal motor seizures (HP:0011153) | 2.36141694 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 2.34644071 |
| 33 | Abnormality of midbrain morphology (HP:0002418) | 2.34644071 |
| 34 | Abnormal ciliary motility (HP:0012262) | 2.33411166 |
| 35 | Broad-based gait (HP:0002136) | 2.31112225 |
| 36 | Optic nerve hypoplasia (HP:0000609) | 2.31092658 |
| 37 | Nephrogenic diabetes insipidus (HP:0009806) | 2.29636283 |
| 38 | Sensory axonal neuropathy (HP:0003390) | 2.28026075 |
| 39 | Tubulointerstitial nephritis (HP:0001970) | 2.24504044 |
| 40 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.23920260 |
| 41 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.23086500 |
| 42 | Abolished electroretinogram (ERG) (HP:0000550) | 2.19941460 |
| 43 | Thrombocytosis (HP:0001894) | 2.19823779 |
| 44 | Absent speech (HP:0001344) | 2.15337420 |
| 45 | Genital tract atresia (HP:0001827) | 2.13360483 |
| 46 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.11800438 |
| 47 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.11800438 |
| 48 | Abnormal drinking behavior (HP:0030082) | 2.10838869 |
| 49 | Polydipsia (HP:0001959) | 2.10838869 |
| 50 | Hypomagnesemia (HP:0002917) | 2.08026318 |
| 51 | Adrenal hypoplasia (HP:0000835) | 2.07752180 |
| 52 | Pancreatic cysts (HP:0001737) | 2.06464482 |
| 53 | Renal cortical cysts (HP:0000803) | 2.06237088 |
| 54 | True hermaphroditism (HP:0010459) | 2.05544640 |
| 55 | Tubulointerstitial abnormality (HP:0001969) | 2.05524774 |
| 56 | 3-Methylglutaconic aciduria (HP:0003535) | 2.05299736 |
| 57 | Retinal dysplasia (HP:0007973) | 2.03552518 |
| 58 | Cerebral edema (HP:0002181) | 2.03105314 |
| 59 | Status epilepticus (HP:0002133) | 2.00707645 |
| 60 | Hypoplasia of the fovea (HP:0007750) | 2.00671772 |
| 61 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.00671772 |
| 62 | Increased serum lactate (HP:0002151) | 2.00078721 |
| 63 | Drooling (HP:0002307) | 1.99905437 |
| 64 | Enlarged kidneys (HP:0000105) | 1.99374808 |
| 65 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.98342377 |
| 66 | Disproportionate short-trunk short stature (HP:0003521) | 1.97172820 |
| 67 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.96751961 |
| 68 | Vaginal atresia (HP:0000148) | 1.94612254 |
| 69 | Attenuation of retinal blood vessels (HP:0007843) | 1.92473036 |
| 70 | Hypoproteinemia (HP:0003075) | 1.91090040 |
| 71 | Congenital stationary night blindness (HP:0007642) | 1.91003556 |
| 72 | Hip dysplasia (HP:0001385) | 1.87325192 |
| 73 | Poor coordination (HP:0002370) | 1.87085977 |
| 74 | Small hand (HP:0200055) | 1.86706619 |
| 75 | Astigmatism (HP:0000483) | 1.84217453 |
| 76 | Optic disc pallor (HP:0000543) | 1.83422019 |
| 77 | Excessive salivation (HP:0003781) | 1.82774762 |
| 78 | Failure to thrive in infancy (HP:0001531) | 1.82474427 |
| 79 | Parakeratosis (HP:0001036) | 1.78898120 |
| 80 | Chromsome breakage (HP:0040012) | 1.78067554 |
| 81 | Abnormality of magnesium homeostasis (HP:0004921) | 1.76315784 |
| 82 | Hepatic necrosis (HP:0002605) | 1.75889480 |
| 83 | Cheilitis (HP:0100825) | 1.73918376 |
| 84 | Tubulointerstitial fibrosis (HP:0005576) | 1.71892797 |
| 85 | Abnormal protein glycosylation (HP:0012346) | 1.71823579 |
| 86 | Abnormal glycosylation (HP:0012345) | 1.71823579 |
| 87 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.71823579 |
| 88 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.71823579 |
| 89 | Lactic acidosis (HP:0003128) | 1.68853432 |
| 90 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.67860446 |
| 91 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.67860446 |
| 92 | Abnormality of lateral ventricle (HP:0030047) | 1.67262510 |
| 93 | Volvulus (HP:0002580) | 1.66676588 |
| 94 | Focal seizures (HP:0007359) | 1.65193201 |
| 95 | Dialeptic seizures (HP:0011146) | 1.64829669 |
| 96 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.64577796 |
| 97 | Absent eyebrow (HP:0002223) | 1.64539334 |
| 98 | Visual hallucinations (HP:0002367) | 1.64089246 |
| 99 | Hypoalbuminemia (HP:0003073) | 1.63924212 |
| 100 | Abnormal albumin level (HP:0012116) | 1.63924212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 8.64413273 |
| 2 | SIK3 | 7.02512310 |
| 3 | BCR | 5.26463731 |
| 4 | FRK | 2.76441855 |
| 5 | TAOK3 | 2.30781772 |
| 6 | MUSK | 2.14077273 |
| 7 | ACVR1B | 2.11917661 |
| 8 | KSR1 | 2.06291559 |
| 9 | WNK3 | 1.71612056 |
| 10 | ERBB3 | 1.64196749 |
| 11 | PAK3 | 1.58348011 |
| 12 | TAF1 | 1.42135755 |
| 13 | WNK4 | 1.39733842 |
| 14 | BMPR1B | 1.36980995 |
| 15 | MAP4K2 | 1.35090363 |
| 16 | GRK1 | 1.24424498 |
| 17 | ADRBK2 | 1.12584359 |
| 18 | MINK1 | 1.11605635 |
| 19 | DAPK2 | 1.11424907 |
| 20 | PLK2 | 1.10437344 |
| 21 | MAP3K4 | 1.09755443 |
| 22 | STK39 | 1.07457457 |
| 23 | MAPK13 | 1.04868443 |
| 24 | TXK | 1.03879962 |
| 25 | CSNK1G2 | 1.00428319 |
| 26 | LIMK1 | 0.99875306 |
| 27 | PAK6 | 0.98078029 |
| 28 | MAP3K3 | 0.97584254 |
| 29 | PINK1 | 0.89376154 |
| 30 | TEC | 0.87978723 |
| 31 | BMPR2 | 0.82492491 |
| 32 | MAP2K7 | 0.82135203 |
| 33 | CASK | 0.81500086 |
| 34 | CSNK1G1 | 0.77809049 |
| 35 | MARK1 | 0.75292385 |
| 36 | CSNK1G3 | 0.75275624 |
| 37 | PRKCE | 0.74189532 |
| 38 | PTK2B | 0.71031554 |
| 39 | CSNK1A1L | 0.66707565 |
| 40 | TESK2 | 0.65629788 |
| 41 | MKNK2 | 0.65232277 |
| 42 | DYRK2 | 0.62622691 |
| 43 | BRD4 | 0.60903003 |
| 44 | PRKCG | 0.60752559 |
| 45 | CDK18 | 0.53605171 |
| 46 | TNK2 | 0.53155533 |
| 47 | CDK19 | 0.50861448 |
| 48 | FER | 0.50560973 |
| 49 | TESK1 | 0.50247197 |
| 50 | NUAK1 | 0.50026520 |
| 51 | INSRR | 0.49536586 |
| 52 | UHMK1 | 0.46466131 |
| 53 | CCNB1 | 0.45695894 |
| 54 | CSNK1A1 | 0.45440284 |
| 55 | CAMK2A | 0.45216442 |
| 56 | PHKG2 | 0.41470380 |
| 57 | PHKG1 | 0.41470380 |
| 58 | OXSR1 | 0.40572709 |
| 59 | KIT | 0.39664826 |
| 60 | OBSCN | 0.38769871 |
| 61 | MAP2K6 | 0.37578125 |
| 62 | PRKACA | 0.37055413 |
| 63 | PRKACB | 0.36763712 |
| 64 | CSNK1E | 0.36029026 |
| 65 | DAPK1 | 0.35091153 |
| 66 | PRKCI | 0.32290744 |
| 67 | TIE1 | 0.31704370 |
| 68 | BRAF | 0.31452029 |
| 69 | BTK | 0.31116672 |
| 70 | SGK2 | 0.31040805 |
| 71 | PRKCB | 0.30825978 |
| 72 | CAMK1 | 0.29874513 |
| 73 | EIF2AK2 | 0.28284606 |
| 74 | NME2 | 0.27440578 |
| 75 | MST4 | 0.26985795 |
| 76 | STK11 | 0.25736394 |
| 77 | ARAF | 0.25547502 |
| 78 | CSNK1D | 0.25466192 |
| 79 | PRKCZ | 0.24905899 |
| 80 | IGF1R | 0.24385343 |
| 81 | PRKCQ | 0.24158439 |
| 82 | PRKCA | 0.24152425 |
| 83 | CDK14 | 0.24001725 |
| 84 | PLK4 | 0.23565122 |
| 85 | PRKG1 | 0.23413474 |
| 86 | GRK7 | 0.23121657 |
| 87 | CAMK2D | 0.23114682 |
| 88 | CDK5 | 0.22957231 |
| 89 | SYK | 0.21215804 |
| 90 | TLK1 | 0.20851612 |
| 91 | CAMKK2 | 0.19863403 |
| 92 | PNCK | 0.19256084 |
| 93 | ERBB2 | 0.18915260 |
| 94 | MAP2K1 | 0.18719941 |
| 95 | CSNK2A1 | 0.18653157 |
| 96 | TRPM7 | 0.18238137 |
| 97 | RPS6KA3 | 0.18129591 |
| 98 | DYRK1A | 0.18021195 |
| 99 | ZAK | 0.17263748 |
| 100 | PRKACG | 0.16672935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.25470919 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.23902767 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.02878842 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.56092487 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.55042111 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.18842278 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.90162265 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 1.87115107 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 1.80740169 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.76449560 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73654090 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.72929923 |
| 13 | Basal transcription factors_Homo sapiens_hsa03022 | 1.72018141 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 1.70882710 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 1.69361339 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64099862 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.63905436 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.62185726 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.60837811 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59530384 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.59366125 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.55548828 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.50616875 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50061684 |
| 25 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.47176022 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.44188029 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.34962783 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.34233158 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.33126060 |
| 30 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.32465176 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32463009 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26138004 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22089744 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.21877330 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.19310982 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.16320000 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13892211 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.09985314 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.09043830 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 1.09036754 |
| 41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.08111960 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08107598 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.04519772 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.03441149 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02639376 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01964348 |
| 47 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00858458 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00002789 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 0.99554047 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.98608712 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98584151 |
| 52 | Long-term depression_Homo sapiens_hsa04730 | 0.97533344 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.96151105 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.94071788 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93148969 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 0.92842419 |
| 57 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87074264 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86200349 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.85209932 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82763792 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81988703 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81008308 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79731510 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 0.77858189 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76705893 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76318798 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 0.73381787 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72022351 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.71782884 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69945860 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69598876 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67980762 |
| 73 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66974478 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66570807 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66133262 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64113671 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.63667486 |
| 78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62935950 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61281656 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60625326 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59268691 |
| 82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58898977 |
| 83 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58519696 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57301897 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56630170 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55830888 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53724866 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.52490532 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51123631 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47605684 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46769983 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45202717 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.44507783 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44128420 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43825862 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.42342965 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41649732 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40028669 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38573354 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34139999 |

